Sugemalimab (Anti-B7-H1 / PD-L1 / CD274)
Product Specifications
CAS Number
2256084-03-2
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Sugemalimab (Anti-B7-H1 / PD-L1 / CD274) is a fully human anti-programmed death ligand 1 (PD-L1) immunoglobulin G4 (IgG4) monoclonal antibody (mAb) . Sugemalimab shows anticancer activities and can be used for non-small-cell lung cancer research. MW: 143.36 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC942216-100 1x 100 µL
CD50 / ICAM3 (CG106), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400863-500 1x 500 µL
Glypican-3 (GPC3/863), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042049-100 1x 100 µL
CD43 (T-Cell Marker) (SPN/2049R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741205-500 1x 500 µL
Nucleolin (364-5 + NCL/902), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 